<DOC>
	<DOCNO>NCT00194610</DOCNO>
	<brief_summary>Patients interstitial cystitis well document pelvic floor muscle tenderness well pain bladder distension . Some investigator even suggest pelvic floor muscle pain primarily cause bladder problem . Botulinum toxin A cause muscle relaxation inhibit acetylcholine release neuromuscular junction . It show mechanism relieve pain number muscle spasm-related syndrome . Because , present , little effective therapy available patient interstitial cystitis , researcher want determine botulinum toxin A relieve bladder pelvic pain patient .</brief_summary>
	<brief_title>Botox Treatment Interstitial Cystitis Women</brief_title>
	<detailed_description>Screening Visit : After screen medical provider , patient give opportunity ask question study . She ask read sign consent randomize . Then , woman childbearing age , pregnancy test do . Next , ask patient fill baseline study form give Voiding Diary . She also ask provide urine sample process chemistry culture . Injection Visit : This visit schedule one week Screening Visit . First , standard history physical do . Then clinician proceed injection . The subject receive injection 5 ml 1 % lidocaine without epinephrine site botulinum toxin A injection . Next , 25 unit Botox inject , via transvaginal route , either side bladder neck . The remain 50 unit inject ( 2 - 25 unit dos ) pelvic sit patient identify tender patient examination . 1 Month Post Injection Mailing : The patient mail packet contain follow-up questionnaire ask mail back upon completion . 6 Week Urine Collection Visit : Two week receive study injection , ask patient go Urology Clinic provide urine sample . 2 Month Post Injection Mailing : Same 1 Month Post Injection Visit . 3 Month Post Visit : The subject ask fill follow-up questionnaire ask turn last set Voiding Diaries .</detailed_description>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Women age 18 old Diagnosis interstitial cystitis Subject severity/stage disease : least 12 voids/day presence pelvic pain Ability follow study instruction likely complete require visit . Negative urine pregnancy test day treatment prior administration study medication ( female childbearing potential ; applicable ) Use medication might interfere neuromuscular function Any medical condition may put subject increase risk exposure Botox include diagnose myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis , disorder might interfere neuromuscular function Females pregnant , breastfeeding , plan pregnancy study think may pregnant start study , female childbearing potential unable unwilling use reliable form contraception study Known allergy sensitivity component study medication Concurrent participation another investigational drug device study , participation 30 day immediately prior study enrollment . Stress incontinence Urinary tract infection time enrollment Overtly psychotic suicidal Pain another source genital tract kidney stone neoplasm Having radiation therapy History genitourinary tuberculosis Neurological abnormality stroke , brain tumor , spinal cord injury Parkinson 's Alzheimer 's disease Currently take antibiotic</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>